Template:SupbiotechparisEn
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
Line 59: | Line 59: | ||
<div id="menu"> | <div id="menu"> | ||
<div style="margin-bottom: 40px; margin-top: 315px; background: transparent;"> | <div style="margin-bottom: 40px; margin-top: 315px; background: transparent;"> | ||
- | '''Project''' | + | <span style="color: black;">'''Project'''</span> |
- | '''Introduction''' | + | <span style="color: black;">'''Introduction'''</span> |
[[Team:SupBiotech-Paris/Current therapies|Current therapies]] | [[Team:SupBiotech-Paris/Current therapies|Current therapies]] | ||
[[Team:SupBiotech-Paris/Gene therapies|Gene therapies]] | [[Team:SupBiotech-Paris/Gene therapies|Gene therapies]] | ||
- | '''1st observation''' | + | <span style="color: black;">'''1st observation'''</span> |
[[Team:SupBiotech-Paris/Introduction1|Introduction]] | [[Team:SupBiotech-Paris/Introduction1|Introduction]] | ||
[[Team:SupBiotech-Paris/Concept1|Concept]] | [[Team:SupBiotech-Paris/Concept1|Concept]] | ||
[[Team:SupBiotech-Paris/Conclusion1|Conclusion]] | [[Team:SupBiotech-Paris/Conclusion1|Conclusion]] | ||
- | '''2nd observation''' | + | <span style="color: black;">'''2nd observation'''</span> |
[[Team:SupBiotech-Paris/Introduction2|Introduction]] | [[Team:SupBiotech-Paris/Introduction2|Introduction]] | ||
[[Team:SupBiotech-Paris/Concept2|Concept]] | [[Team:SupBiotech-Paris/Concept2|Concept]] | ||
[[Team:SupBiotech-Paris/Conclusion2|Conclusion]] | [[Team:SupBiotech-Paris/Conclusion2|Conclusion]] | ||
- | '''Implementation''' | + | <span style="color: black;">'''Implementation'''</span> |
[[Team:SupBiotech-Paris/Tissue targeting|Tissue targeting]] | [[Team:SupBiotech-Paris/Tissue targeting|Tissue targeting]] | ||
[[Team:SupBiotech-Paris/Cell targeting|Cell targeting]] | [[Team:SupBiotech-Paris/Cell targeting|Cell targeting]] | ||
Line 78: | Line 78: | ||
- | '''Ressources''' | + | <span style="color: black;">'''Ressources'''</span> |
[[Team:SupBiotech-Paris/Biobricks|Biobricks]] | [[Team:SupBiotech-Paris/Biobricks|Biobricks]] | ||
[[Team:SupBiotech-Paris/Material & Method|Material & Method]] | [[Team:SupBiotech-Paris/Material & Method|Material & Method]] | ||
Line 84: | Line 84: | ||
- | '''Ethic & Safety''' | + | <span style="color: black;">'''Ethic & Safety'''</span> |
[[Team:SupBiotech-Paris/Synthetic Biology|Synthetic Biology]] | [[Team:SupBiotech-Paris/Synthetic Biology|Synthetic Biology]] | ||
[[Team:SupBiotech-Paris/Our project|Our project]] | [[Team:SupBiotech-Paris/Our project|Our project]] |
Revision as of 18:05, 2 September 2009